雅虎香港 搜尋

搜尋結果

1. 

   里斯本與賓菲加體育

   八強賽

   歐霸盃, Leg 2 of 2

   Apr 18, 賽果

   

   馬賽

   1(4)

   -

   0(2)

   Orange Velodrome

   

   賓菲加

   F. Moumbagna (79')

   其他比賽

   歐霸盃					終場
   4月 11日	vs		馬賽		W 2 - 1
   賽事分析

   • A 組
   • B 組
   • C 組
   • D 組
   • E 組
   • F 組
   • G 組
   • H 組

   A 組		GP	W	D	L	Pts
   1 拜仁慕尼黑		6	5	1	0	16
   2 Copenhagen		6	2	2	2	8
   3 Galatasaray		6	1	2	3	5
   4 曼聯		6	1	1	4	4

   B 組		GP	W	D	L	Pts
   1 阿仙奴		6	4	1	1	13
   2 PSV燕豪芬		6	2	3	1	9
   3 朗斯		6	2	2	2	8
   4 塞維利亞		6	0	2	4	2

   C 組		GP	W	D	L	Pts
   1 皇家馬德里		6	6	0	0	18
   2 拿玻里		6	3	1	2	10
   3 Braga		6	1	1	4	4
   4 柏林聯		6	0	2	4	2

   D 組		GP	W	D	L	Pts
   1 皇家蘇斯達		6	3	3	0	12
   2 國際米蘭		6	3	3	0	12
   3 賓菲加		6	1	1	4	4
   4 薩爾斯堡		6	1	1	4	4

   E 組		GP	W	D	L	Pts
   1 馬德里體育會		6	4	2	0	14
   2 拉素		6	3	1	2	10
   3 Feyenoord		6	2	0	4	6
   4 些路迪		6	1	1	4	4

   F 組		GP	W	D	L	Pts
   1 多蒙特		6	3	2	1	11
   2 巴黎聖日耳門		6	2	2	2	8
   3 AC米蘭		6	2	2	2	8
   4 紐卡素		6	1	2	3	5

   G 組		GP	W	D	L	Pts
   1 曼城		6	6	0	0	18
   2 RB萊比錫		6	4	0	2	12
   3 Young Boys		6	1	1	4	4
   4 Crvena Zvezda		6	0	1	5	1

   H 組		GP	W	D	L	Pts
   1 巴塞隆拿		6	4	0	2	12
   2 波圖		6	4	0	2	12
   3 薩克達		6	3	0	3	9
   4 Royal Antwerp		6	1	0	5	3

2. www.polyu.edu.hk › riiwear › people費賓教授 | 智能可穿戴系統研究院 - The Hong Kong Polytechnic ...

   www.polyu.edu.hk › riiwear › people

   • 網頁紀錄

   SCOPUS ID. 簡歷. Dr. Bin FEI obtained BSc (1996) from the University of Science & Technology of China and PhD (2003) from the Changchun Institute of Applied Chemistry, Chinese Academy of Sciences. After postdoctoral researches, he joined ITC of PolyU in 2010, and became Associate Professor in 2016.

3. www.polyu.edu.hk › riiwear › peopleProf. Bin FEI | Research Institute for Intelligent Wearable ...

   www.polyu.edu.hk › riiwear › people

   • 網頁紀錄

   Biography. Dr. Bin FEI obtained BSc (1996) from the University of Science & Technology of China and PhD (2003) from the Changchun Institute of Applied Chemistry, Chinese Academy of Sciences. After postdoctoral researches, he joined ITC of PolyU in 2010, and became Associate Professor in 2016.

4. www.polyu.edu.hk › pri › peopleProf. FEI Bin | Photonics Research Institute - The Hong Kong ...

   www.polyu.edu.hk › pri › people

   • 網頁紀錄

   Biography. Dr. Bin FEI obtained BSc (1996) from the University of Science & Technology of China and PhD (2003) from the Changchun Institute of Applied Chemistry, Chinese Academy of Sciences. After postdoctoral researches, he joined ITC of PolyU in 2010, and became Associate Professor in 2016.

5. www.polyu.edu.hk › riiwear › people徐賓剛教授 | 智能可穿戴系統研究院 - The Hong Kong ...

   www.polyu.edu.hk › riiwear › people

   • 網頁紀錄

   Prof. Xu has published over 200 book chapters, journal and conference papers, and also holds 12 granted patents. His research interests include smart wearables, wearable electronics, energy conversion and storage, computer vision and artificial intelligence. Prof.

6. www.polyu.edu.hk › study › pgDoctor of Philosophy (PhD) / Master of Philosophy (MPhil)

   www.polyu.edu.hk › study › pg

   • 網頁紀錄

   The expertise of BEEE academic staff spans a wide range of disciplines, including the aspects of sustainability; building energy, heating, ventilation and air-conditioning systems; fire and safety engineering; electrical technology; public health; indoor environmental engineering; architectural engineering; computer-aided design and facilities m...

7. www.polyu.edu.hk › me › studyMPhil/PhD in Mechanical Engineering 機械工程學哲學碩士/博士 ...

   www.polyu.edu.hk › me › study

   • 網頁紀錄

   Study. Research Postgraduate Programme. MPhil/PhD in Mechanical Engineering 機械工程學哲學碩士/博士學位課程. Introduction Admission Scholarships. Click to learn more ... As one of the founding departments of the University in 1937, the Department of Mechanical Engineering has been at the forefront of the vast evolvement of its field.

8. www.polyu.edu.hk › abct › researchNovel Anti-Cancer Biological Drug, BCA-PEG20 | Department of ...

   www.polyu.edu.hk › abct › research

   • 網頁紀錄

   BCA-PEG20 has potent anti-cancer activities on a variety of cancers, including lung cancer, colorectal cancer, liver cancer, breast cancer, gastric and esophageal cancers. Our drug also shows synergy with chemo drugs to enhance therapeutic effects.